Bard acquires nitinol stent technology
This article was originally published in The Gray Sheet
Executive Summary
Firm will record a charge of approximately $6 mil. in the first quarter related to its acquisition of certain assets for self-expanding nitinol stent technology from Gainesville, Fla.-based PST, the firm announces Jan. 18. Bard plans to launch a carotid stent in Europe in the second half of 2006 and in the U.S. in 2009 (1"The Gray Sheet" July 25, 2005, p. 22)...